Entity Common Stock, Shares Outstanding of Larimar Therapeutics, Inc. from 11 Aug 2014 to 03 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Larimar Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 11 Aug 2014 to 03 Nov 2025.
  • Larimar Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 03 Nov 2025 was 85,590,392, a 34% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Larimar Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 85,590,392 +21,783,764 +34% 03 Nov 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 85,590,392 +21,783,764 +34% 12 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 64,027,892 +227,875 +0.36% 20 Mar 2025 10-K 24 Mar 2025 2024 FY
Q3 2024 63,806,628 +19,900,725 +45% 28 Oct 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 63,806,628 +20,529,128 +47% 06 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 63,800,017 +20,530,817 +47% 12 Mar 2024 10-K 14 Mar 2024 2023 FY
Q3 2023 43,905,903 +636,703 +1.5% 12 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 43,277,500 +25,567,050 +144% 07 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 43,269,200 +25,558,750 +144% 13 Mar 2023 10-K 14 Mar 2023 2022 FY
Q3 2022 43,269,200 +25,558,750 +144% 08 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 17,710,450 0 0% 09 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 17,710,450 +2,342,720 +15% 23 Mar 2022 10-K 25 Mar 2022 2021 FY
Q3 2021 17,710,450 +2,354,244 +15% 10 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 17,710,450 +2,354,244 +15% 10 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 15,367,730 -22,101,866 -59% 02 Mar 2021 10-K 04 Mar 2021 2020 FY
Q3 2020 15,356,206 -22,017,912 -59% 31 Oct 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 15,356,206 -22,014,095 -59% 31 Jul 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 37,469,596 +142,701 +0.38% 30 Apr 2020 10-Q 07 May 2020 2020 Q1
Q3 2019 37,374,118 +503,338 +1.4% 31 Oct 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 37,370,301 +564,710 +1.5% 31 Jul 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 37,326,895 +9,763,549 +35% 30 Apr 2019 10-Q 09 May 2019 2019 Q1
Q3 2018 36,870,780 +9,381,323 +34% 31 Oct 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 36,805,591 +9,321,666 +34% 31 Jul 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 27,563,346 +190,495 +0.7% 30 Apr 2018 10-Q 10 May 2018 2018 Q1
Q3 2017 27,489,457 +156,906 +0.57% 31 Oct 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 27,483,925 +154,692 +0.57% 31 Jul 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 27,372,851 +103,908 +0.38% 30 Apr 2017 10-Q 09 May 2017 2017 Q1
Q3 2016 27,332,551 +98,009 +0.36% 31 Oct 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 27,329,233 +205,768 +0.76% 31 Jul 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 27,268,943 +412,614 +1.5% 07 Mar 2016 10-K 15 Mar 2016 2015 FY
Q3 2015 27,234,542 +4,527,132 +20% 30 Oct 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 27,123,465 +4,416,453 +19% 31 Jul 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 26,856,329 17 Mar 2015 10-K 25 Mar 2015 2014 FY
Q3 2014 22,707,410 11 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 22,707,012 11 Aug 2014 10-Q 14 Aug 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.